Related Experiment Video

Updated: Aug 8, 2026

Induction and Testing of Hypoxia in Cell Culture
07:01

Induction and Testing of Hypoxia in Cell Culture

Published on: August 12, 2011

Hypoxia stimulates p16 expression and association with cdk4

Adam Zygmunt1, Vivienne C Tedesco, Eshwar Udho

  • 1Department of Biological Sciences, Pace University, Pleasntville, New York 10570, USA.

Experimental Cell Research
|July 20, 2002
PubMed

Insights

Hypoxia inhibits cell proliferation by inactivating cyclin-dependent kinase 4 (cdk4). This inactivation is mediated by increased levels of p16, a cyclin-dependent kinase inhibitor, which binds to cdk4 under hypoxic conditions.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Hypoxic conditions trigger cell proliferation inhibition.
  • Hypoxia leads to the accumulation of hypophosphorylated retinoblastoma protein (pRb), a growth-suppressive form.
  • This inhibition is partly due to reduced activity of pRb-directed cyclin-dependent kinases (cdk4 and cdk2).

Purpose of the Study:

  • To elucidate the mechanism of cdk4 inactivation under hypoxic conditions.
  • To investigate the role of cyclin-dependent kinase inhibitors (cdkis) in hypoxia-induced cell cycle arrest.

Main Methods:

  • Cell cycle analysis of CV-1P cells under hypoxic and aerobic conditions.
  • Analysis of cdk4, cdk6, D-type cyclins, and various cdkis (p16, p18, p19, p57) levels.
  • Immunoprecipitation assays to detect p16-cdk4 binding.

Main Results:

  • Hypoxia inhibited CV-1P cell progression from G1 to S phase after 18 hours.
  • Dephosphorylation of serine-795, a putative cdk4 substrate, occurred under hypoxia.
  • While cdk4, cdk6, and D-type cyclin levels remained unchanged, p16 levels significantly increased under hypoxia.
  • Immunoprecipitation confirmed p16 binding to cdk4 specifically under hypoxic conditions.

Conclusions:

  • Hypoxia-induced cell proliferation inhibition in CV-1P cells is associated with cdk4 inactivation.
  • Increased p16 levels and its subsequent binding to cdk4 appear to mediate cdk4 inhibition under hypoxia.
  • p16 may play a crucial role in the growth inhibitory effects of hypoxia.

More Related Videos

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

Anaerobic Growth and Maintenance of Mammalian Cell Lines07:15

Anaerobic Growth and Maintenance of Mammalian Cell Lines

Published on: July 21, 2018

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...